IDYA Return on Tangible Equity | IDEAYA Biosciences, Inc.

IDEAYA Biosciences, Inc. (IDYA) Return on Tangible Equity

2026-06-30: Return Tang Equity -14.60%.
2026-03-31: Return Tang Equity -14.94%.
2025-12-31: Return Tang Equity -11.11%.
2025-09-30: Return Tang Equity -14.72%.

Complete source-backed return tang equity history.

Available history: 2017-12-31 to 2026-06-30
Data captured: 2026-09-04

Historical Return Tang Equity

Date	Return Tang Equity
2026-06-30	-14.60%
2026-03-31	-14.94%
2025-12-31	-11.11%
2025-09-30	-14.72%
2025-06-30	-34.58%
2025-03-31	-29.98%
2024-12-31	-25.91%
2024-09-30	-15.09%
2024-06-30	-16.50%
2024-03-31	-13.78%
2023-12-31	-18.19%
2023-09-30	-20.31%
2023-06-30	-14.78%
2023-03-31	-20.46%
2022-12-31	-16.78%
2022-09-30	-14.28%
2022-06-30	-24.46%
2022-03-31	-18.97%
2021-12-31	-16.50%
2021-09-30	-11.55%
2021-06-30	-12.50%
2021-03-31	-13.50%
2020-12-31	-17.40%
2020-09-30	-20.54%
2020-06-30	-26.84%
2020-03-31	-49.88%
2019-12-31	-41.81%
2019-09-30	-36.01%
2019-06-30	-34.69%
2019-03-31	65.75%

Annual Return Tang Equity

Date	Return Tang Equity
2025-12-31	-11.11%
2024-12-31	-25.91%
2023-12-31	-18.19%
2022-12-31	-16.78%
2021-12-31	-16.50%
2020-12-31	-17.40%
2019-12-31	-41.81%
2018-12-31	70.17%
2017-12-31	75.37%

Similar stocks

Stock Name	Country	Market Cap	PE Ratio
Organon & Co. (OGN)	United States	$3.603B	17.03
Xenon Pharmaceuticals Inc. (XENE)		$3.684B	-14.27
Amylyx Pharmaceuticals, Inc. (AMLX)	United States	$3.361B	-13.15
Enliven Therapeutics, Inc. (ELVN)	United States	$3.307B	-35.07
Arcutis Biotherapeutics, Inc. (ARQT)	United States	$3.303B	115.47
ACADIA PHARMACEUTICALS INC (ACAD)	United States	$3.823B	11.45
AbCellera Biologics Inc. (ABCL)		$3.879B	-14.59
Arcus Biosciences, Inc. (RCUS)	United States	$3.188B	-8.52
Dyne Therapeutics, Inc. (DYN)	United States	$3.084B	-7.09
Tango Therapeutics, Inc. (TNGX)	United States	$4.154B	-42.53